Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells

In conclusion, our findings demonstrate that EIF5A2 has a critical role in HCC cell metabolic reprogramming and may serve as a prominent novel therapeutic target for liver cancer treatment.

Source: Carcinogenesis - January 5, 2017 Category: Cancer & Oncology Authors: Cao, T.-T., Lin, S.-H., Fu, L., Tang, Z., Che, C.-M., Zhang, L.-Y., Ming, X.-Y., Liu, T.-F., Tang, X.-M., Tan, B.-B., Xiang, D., Li, F., Chan, O.-Y., Xie, D., Cai, Z., Guan, X.-Y. Tags: Original Manuscript Source Type: research